MYP_105887
Basic Information
MBD-4 (11-40)(P9)
Anticancer Cytotoxic anticancer activity Cytotoxic
Antimicrobial
Antiviral
Antiviral Anti-Coronavirus Anti-SARS-CoV
Antiviral Anti-Coronavirus Anti-SARS-CoV-2
Antiviral Anti-Influenza virus Anti-Influenza A Anti-Influenza A virus
Antiviral Antiviral mechanism Viral replication inhibition
Membrane / Ion-channel modulation Sodium channel modulation Sodium channel inhibitor
Toxicity / Safety Cytotoxicity Cytotoxic
Venom / Toxin General toxin Cytotoxic
Standard
30 amino acids
C144H227N47O35S5
Standard
Sequence
NGAICWGPCPTAFRQIGNCGHFKVRCCKIR
Physicochemical Analysis
3336.96 Da
9.41
4.80
4.47
0.1599
-0.07
0.60
-0.01
-1.33
55.33
0.1000
5500.00
5750.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1321.35
-13.90
51.0
46.0
105.0
231.0
7.0
32.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0010782 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2
Virus:Human Influenza A Virus H1N1
1.2 μg/mL
IC50
RECORD: Rec_0014783 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Anti-SARS-CoV-2
SARS-CoV-2:Inhibition of infection in Vero E6 cells
2.4 μg/mL
IC50
RECORD: Rec_0034466 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-Influenza A virus Replication inhibition
Human Influenza A Virus H7N7
0.8 μg/mL
IC50
Mammalian: 1.4 h; Yeast: 3 min; E. coli: >10 h
RECORD: Rec_0062332 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-SARS-CoV Replication inhibition
SARS-CoV
4.8 μg/mL
IC50
Mammalian: 1.4 h; Yeast: 3 min; E. coli: >10 h
RECORD: Rec_0069999 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Defensin
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
and H7N7
1 2 3 ... 8 NEXT LAST
Showing 5 records on this page · Page 1 of 8